Press release
4th Annual Pharma Supply-Chain & Security World 2022
The Annual Pharma Supply Chain and Security World Summit is a major global event for the pharmaceutical industry, bringing together the whole Pharma Supply Chain community for two days of discussion on new developments, technologies, strategies and best practices to ensure an agile, responsive, streamlined and a secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance with regulatory requirements for serialisation of medicines in emerging markets. The rise of the digital supply chain has been accompanied by an ever-increasing number of regulations that have accelerated its development and adoption. Years ago, the pharmaceutical supply chain regulated only manufacturing and distribution. However, with a rise in economic impact of counterfeit drugs on society, there have been attempts to improve serialisation processes even further.In spite of past obstacles, innovations like IoT, AI and ML (and Blockchain) have led us into an exciting era of digitization within our industry. Data-driven algorithms and analytics will transform the pharmaceutical supply chain, helping it become more intuitive. With AI's predictive power combined with ML capabilities to analyse data in a speedy fashion, pharma companies can use this information towards making smarter decisions that lead to greater success throughout all stages of their operations. Combining AI with other advanced technologies, such as blockchain, can create a system that is immutable and transparent. This will also allow for the security of products to be improved in the long run by shielding from counterfeit drugs or substandard medicines.
Corvus Global Events invites you to 4th Annual Pharma Supply Chain & Security World 2022 - Supply-chain, Drug Serialization and Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.
It gives us a great pleasure to welcoming you to the 4th Annual Pharma Supply Chain & Security World 2022.
Key Highlights
Streamlining your supply chain
End to End supply chain visibility
Designing an optimal supply chain network
Strategies for drug anti-counterfeiting in global supply chain and improving security through an interlinked supply chain strategy
Developing a sustainable Serialization strategy
Integration of track & trace solutions in production and supply chain
Smart Packaging, Labelling and Artwork
Warehouse & Logistics
Serialization Data and Analytics driven approach to increase supply chain agility
Adoption of Blockchain in pharma supply chain
Intelligent Automation enabling Industry 4.0
The need to understand and adopt new technologies like IoT, Analytics, Machine Learning and Artificial Intelligence
Effective Authentication Technologies
Best selection of tamper-evident features
Brand Protection & Securing supply chain integrity
Global enterprise level solutions for anti-counterfeiting
Tackling pharmaceutical crime - initiatives at multinational, EU and national level
IP and regulatory enforcement
Synchrony of the Pharma Industry and professional bodies against counterfeiting
Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
Strategies for public awareness and patient protection
Best practices to protect your brand
The role of the Internet in aiding the counterfeiters – How to overcome the situation?
How Pharma Industry and professional bodies are fighting against counterfeiting
Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
Case study: How companies are structuring their counterfeiting efforts and departments?
Who should attend the conference?
Attendees include GMs, VPs, Directors, Heads and Managers of:
Pharmaceutical manufacturers and distributors
Supply Chain management companies
Serialization, Track and Trace solution providers
Packaging & labelling
Authentication technology suppliers
Operations/Portfolio management
Production process
Quality/Compliance Management
Manufacturing Automation
Digital Innovation (Block Chain, AI, ML)
Data Analytics
Contract manufacturing organisation (CMO)
Contract packaging organisation (CPO)
Brand protection, enforcement, security, integrity and management companies
Healthcare research organizations
Pharmaceutical industry professional associations
Anti-counterfeiting organizations
IT service providers
Cloud & Big Data
Intellectual Property, investigators and Trademark council
Drug regulatory agencies and customs
Pharmacists
85 Great Portland Street
First Floor
London W1W 7LT
Our conferences give an unique opportunity for knowledge exchange and discussions in a very professional setting. Experience a peer-to-peer connection and knowledge sharing through our exclusive networking opportunities that leads to innovation and collaboration. Our programme sessions are meticulously researched to give our delegates an excellent quality agenda and we strive to place our attendees at the center of everything we do for the conference
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 4th Annual Pharma Supply-Chain & Security World 2022 here
News-ID: 2433098 • Views: …
More Releases from Corvus Global Events

Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.
As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes…

Pharma Supply Chain & Security World 2025
The Annual Pharma Supply Chain & Security World Summit is back in London for the 6th time, and this time with more focus on optimising your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…